Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
Main Authors: | Hagen, N, Hauk, C, Heide, L |
---|---|
Other Authors: | Brombacher, D |
Format: | Book section |
Language: | English |
Published: |
Nomos
2022
|
Similar Items
-
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
by: Hauk, C, et al.
Published: (2021) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Cavany, S, et al.
Published: (2023) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
by: Sean Cavany, et al.
Published: (2023-10-01) -
How to achieve international action on falsified and substandard medicines.
by: Attaran, A, et al.
Published: (2012) -
Substandard and Falsified Medicines: Proposed Methods for Case Finding and Sentinel Surveillance
by: Elizabeth Pisani, et al.
Published: (2021-08-01)